Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning
Condition(s) studied
Study summary
This study looks at patients admitted to intensive care for drug poisoning involving metformin, a common diabetes medication. Researchers will compare two groups: patients who overdosed on metformin alone and those who took both metformin and dapagliflozin, another diabetes drug. The goal is to find clinical or laboratory signs that could help doctors quickly recognize a dapagliflozin overdose in this context, which could improve treatment and patient outcomes.
Eligibility
Primary outcome measure(s)
- Identification of clinical and biological differences between patients admitted to intensive care for metformin overdose alone versus those with combined metformin and dapagliflozin overdose. — 10 years
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Centre Hospitalier de Saint-Denis | Saint-Denis | France | Recruiting |
More Centre Hospitalier de Saint-Denis trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07193069 on ClinicalTrials.gov ↗ ← All trials in France